Announcement on Resolutions of the 3rd General Meeting in 2025
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
The meeting was held to discuss various proposals, including the provision for bad debts. The resolutions passed without any objections from shareholders present at the meeting.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix
Earlier from Shaanxi Kanghui Pharmaceutical
- Announcement on Applying for Arbitration Regarding Performance Compensation Matters
- Announcement on Wholly-owned Subsidiary Completing Industrial and Commercial Change Registration
- Announcement on Change of Drug Production License
- Notice on Convening the 3rd Extraordinary General Meeting in 2025
- Announcement on Progress in Lawsuit and Receipt of Notice of Withdrawal of Lawsuit
Later from Shaanxi Kanghui Pharmaceutical
- Announcement on Increasing the Estimated Amount for Daily Related Party Transactions in 2025
- Announcement on Applying for Arbitration Regarding Performance Compensation Matters and Accumulated Litigation
- Announcement on Providing Guarantee for Holding Subsidiary
- Notice on Convening the 4th Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 4th General Meeting in 2025
Follow Shaanxi Kanghui Pharmaceutical into a list and get an email when it puts out news.
Follow Shaanxi Kanghui Pharmaceutical